Brean Murray upgrades China Medical Technologies (Nasdaq: CMED) from Hold to Buy with a $55 price target.

The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE